Market Price

0.26 

0.00 0.0%

as of Jun 20 '19

52 Week Range:

0.01 0.44


Stock Analyzer Tutorials

S2O Stock Analyzer - General Info

General Info


type: video (mp4); length: 3:30

Demonstrates how to use Stock Analyzer, shows how to analyze a stock and explains in detail "General Info" section of the Stock Analyzer result page.

S2O Stock Analyzer - Financial Statements

Financial Statements


type: video (mp4); length: 5:10

Explains information presented in the Financial Statements section of the S2O Stock Analyzer: financial statements charts, absolute values and growth rates.

S2O Stock Analyzer - Growth Grade and Financial Ratios

Growth Grade and Financial Ratios


type: video (mp4); length: 5:09

Demonstrates how to use Growth Grade & Financial Ratios section; shows the difference between historical and year-over-year Growth Grade on the real life example.

S2O Stock Analyzer - Value Price

Value Price


type: video (mp4); length: 6:03

Demonstrates how to use Value Price (intrinsic value) and the Graham Number, MOS (margin of safety) and IRT - Investment Recovery Time; explains 3 different projection models used to compute value price - pessimistic, moderate and optimistic.

S2O Stock Analyzer - Price Charts

Price Charts


type: video (mp4); length: 8:34

Demonstrates basic rules of how to read a candlestick chart, long and short term moving averages, stochastic, MACD and relative strength (RS) charts. Explains how bull or bear market condition is computed.

General Info

OmniComm Systems, Inc., a healthcare technology company, provides Web-based electronic data capture (EDC), and eClinical software and services for pharmaceutical and biotechnology companies, clinical research organizations (CROs), and other clinical trial sponsors worldwide. It offers TrialMaster, which allows organizations conducting clinical trials to collect and manage the data over the Internet; TrialOne Phase I Clinic Automation, a software application suite that provides clinical trial site sponsors, study investigators, and study monitors with various tools to conduct the Phase I clinic operation; and IRTMaster, which offers interactive response technology in support of the randomization process in clinical trials. The company also provides eClinical Suite that comprises a set of tools for collecting and managing clinical data, including EDC for real-time entry and double data entry (DDE) for entry from paper originals; and Promasys, a clinical trial data management system for DDE and EDC, which is primarily used at research institutions for investigator-initiated trials. In addition, it offers Acuity, a clinical data aggregation and analytics platform that provides actionable insights into quality, risk, and performance of various aspects of clinical trials in real time. Further, the company provides consulting and professional services, such as project management, clinical services, training, custom configuration, system integration, standard operating procedures and implementation assistance, installation, and validation services, as well as application hosting and related support services. It sells its products through a direct sales force and relationships with CRO partners, as well as through co-marketing agreements with vendor and channel partners. OmniComm Systems, Inc. was founded in 1996 and is headquartered in Fort Lauderdale, Florida.

Financial Statements

The charts below show selected Annual and Quarterly Financial Data.

The purpose of these charts is to discover long and short term change dynamics. When numbers are growing year after year in the annual statements chart, the business become stronger and stronger and this is a good sign.

Quarterly Data Chart can be used to do a short term analysis. It makes sense to pay attention to the quarterly dynamics and do not wait for the next yearly statement. We should be alerted if we see that quarterly numbers are going down.

You can check "Annual Financial Statements" and "Quarterly Financial Statements" sections for exact numbers and growth rates.

Annual Statements

On a charts below the Line shows absolute values and the Bar chart shows Year-Over-Year Growth Rate for selected financial statement item. A consistent GROWTH is generally considered necessary to fund future growth from within a business.
NOTE: Growth Rate is not provided if either the latest period or the year-ago period contains a net loss. (source: WSJ Digest of Earnings)
TIP! move your mouse pointer over bar or a circle on any chart below to see details.

Financial Statements

Income Statement



 

Cash Flow Statement



 

Balance Sheet



 

Liquidity Ratios

Current Ratio


 

Current Ratio measures the ability to meet short term obligations. Generally accepted standard is 2 (current assets should be 2 times or 200% of current liabilities).

Quick Ratio


 

Measures immediate liquidity or the cash available to cover immediate liabilities. A safe margin would be at least 1 (100%).

Financial Leverage


 

Defined as total assets divided by total shareholders' equity. The higher the ratio, the more debt a company uses in its capital structure.

Profitability Ratios

ROA


 

Return on Assets (ROA) measures the income (profit) that is generated by the use of the assets of the business.

ROE


 

Return on Equity (ROE) is a measure of profitability that calculates how many dollars of profit a company generates with each dollar of shareholders equity. ROE is sometimes called "return on net worth."

ROIC


 

The Return on Invested Capital (ROIC) measure gives a sense of how well a company is using its money to generate returns. Some investors use this figure as a final evaluation to determine whether or not to invest in a company.

Annual Statements

Item Name Dec '08 Dec '09 Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18
Equity (BVPS) -0.14
-0.19
-0.20
-0.26
-0.33
-0.37
-0.34
-0.24
-0.16
-0.12
-0.11
growth rate 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Earnings BIT -1.70
1.50
4.26
3.43
2.61
growth rate 100.0% 184.5% -19.6% -23.7%
Avg.PE 6.33
7.83
9.00
20.67
growth rate 23.7% 14.9% 129.7%
ROA -299.22
-145.48
-66.94
-94.46
-246.01
-89.90
-88.74
39.68
1.41
33.33
37.06
growth rate 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 100.0% -96.5% 2,263.8% 11.2%
Cur. Ratio 0.88
0.47
0.20
0.29
0.14
0.15
0.19
0.41
0.44
0.58
0.75
growth rate -46.6% -57.5% 45.0% -51.7% 7.1% 26.7% 115.8% 7.3% 31.8% 29.3%
Quick Ratio 0.86
0.43
0.19
0.27
0.14
0.14
0.18
0.38
0.42
0.56
0.72
growth rate -50.0% -55.8% 42.1% -48.2% 0.0% 28.6% 111.1% 10.5% 33.3% 28.6%
Balance Sheet Dec '08 Dec '09 Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18
Acct.Receivable 1.60
3.42
4.09
5.46
7.49
6.18
growth rate 113.5% 19.8% 33.3% 37.4% -17.6%
Acct.Payable 2.54
0.61
0.52
0.70
1.30
0.90
growth rate -75.9% -15.9% 35.2% 86.9% -31.3%
Cur.Assets 2.91
4.34
5.29
7.27
8.98
8.01
growth rate 49.3% 21.9% 37.6% 23.4% -10.8%
Total Assets 4.71
5.80
6.32
8.13
9.67
10.23
growth rate 23.2% 8.9% 28.7% 19.0% 5.7%
Cash 1.16
0.52
0.84
1.44
1.18
1.44
growth rate -55.0% 59.7% 72.3% -18.3% 22.4%
Cur.Liabilities 19.05
22.41
12.87
16.61
15.44
10.64
growth rate 17.6% -42.6% 29.1% -7.1% -31.1%
Liabilities 36.17
41.58
27.74
29.26
26.87
21.91
growth rate 14.9% -33.3% 5.5% -8.2% -18.5%
LT Debt 1.08
16.10
12.21
10.25
9.48
9.30
growth rate 1,392.4% -24.2% -16.1% -7.6% -1.8%
Equity -40.50
-25.65
-22.13
-18.19
-12.68
growth rate 0.0% 0.0% 0.0% 0.0%
Common Shares 72.00
81.00
86.00
86.00
87.00
88.00
91.00
114.00
146.00
148.00
165.00
growth rate 12.5% 6.2% 0.0% 1.2% 1.2% 3.4% 25.3% 28.1% 1.4% 11.5%
Cash Flow Statement Dec '08 Dec '09 Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18
Capital Expenditures 0.35
0.10
0.45
0.26
0.24
0.85
growth rate -71.3% 344.0% -42.2% -6.9% 250.4%
Cash From OA -1.23
0.66
2.52
0.87
1.22
growth rate 100.0% 283.3% -65.6% 40.8%
FCF per Share -0.08
-0.07
-0.03
-0.01
-0.01
-0.02
-0.02
0.01
0.02
growth rate 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 100.0% 100.0%
Sale Purchase of Stock 0.03
0.03
0.13
0.19
growth rate 0.0% 374.4% 47.0%
FCF -6.00
-5.00
-2.00
-1.00
-3.00
-1.00
0.21
2.00
1.00
0.37
growth rate 0.0% 0.0% 0.0% 0.0% 0.0% 100.0% 869.9% -50.0% -63.0%
Income Statement Dec '08 Dec '09 Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18
Sales 14.33
16.02
20.02
24.39
26.07
26.13
growth rate 11.8% 25.0% 21.8% 6.9% 0.2%
Op.Income -3.16
-1.70
1.50
4.26
3.43
2.61
growth rate 0.0% 100.0% 184.5% -19.6% -23.7%
IBT -3.07
-4.48
2.56
0.10
2.97
4.18
growth rate 0.0% 100.0% -96.0% 2,784.7% 40.8%
Net Income -3.16
-4.46
2.59
0.10
2.97
3.69
growth rate 0.0% 100.0% -96.1% 2,811.9% 24.3%
EPS -0.15
-0.10
-0.04
-0.04
-0.09
-0.04
-0.05
0.02
0.02
0.02
growth rate 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 100.0% 0.0% 0.0%
Gross Profit 11.42
12.77
16.25
20.48
21.67
21.84
growth rate 11.8% 27.3% 26.0% 5.8% 0.8%

Quarterly Statements

Item Name Mar '18 Jun '18 Sep '18 Dec '18 Mar '19
Earnings BIT 0.91
0.27
0.75
0.69
-0.40
growth rate -70.5% 180.0% -7.3% -100.0%
Balance Sheet Mar '18 Jun '18 Sep '18 Dec '18 Mar '19
Acct.Receivable 5.99
6.65
5.12
6.18
3.99
growth rate 10.9% -22.9% 20.5% -35.4%
Acct.Payable 0.68
0.55
0.76
0.90
0.47
growth rate -19.6% 38.8% 17.7% -47.1%
Cur.Assets 7.46
8.00
6.90
8.01
5.61
growth rate 7.2% -13.7% 16.0% -30.0%
Total Assets 9.18
10.19
9.18
10.23
9.41
growth rate 11.0% -9.9% 11.4% -8.0%
Cash 1.18
1.12
1.37
1.44
1.35
growth rate -5.0% 22.8% 5.0% -6.2%
Cur.Liabilities 12.10
11.81
14.64
10.64
9.76
growth rate -2.4% 24.0% -27.3% -8.3%
Liabilities 25.22
24.62
26.19
21.91
21.72
growth rate -2.4% 6.4% -16.3% -0.9%
LT Debt 11.28
10.86
9.69
9.30
9.90
growth rate -3.8% -10.8% -3.9% 6.4%
Equity -17.04
-15.43
-18.01
-12.68
-13.31
growth rate 0.0% 0.0% 0.0% 0.0%
Common Shares 0.15
0.15
0.15
0.16
0.16
growth rate 0.1% 1.3% 2.0% 1.9%
Cash Flow Statement Mar '18 Jun '18 Sep '18 Dec '18 Mar '19
Capital Expenditures 0.09
0.35
0.26
0.15
0.27
growth rate 272.6% -24.4% -42.9% 81.3%
Cash From OA -1.10
0.42
1.81
0.10
0.17
growth rate 100.0% 331.7% -94.6% 71.3%
Sale Purchase of Stock
growth rate
FCF -1.20
0.07
1.55
-0.05
-0.10
growth rate 100.0% 2,025.5% -100.0% 0.0%
Income Statement Mar '18 Jun '18 Sep '18 Dec '18 Mar '19
Sales 7.04
6.14
6.38
6.57
5.53
growth rate -12.8% 4.0% 3.0% -15.8%
Op.Income 0.91
0.27
0.75
0.69
-0.40
growth rate -70.5% 180.0% -7.3% -100.0%
IBT 0.59
1.53
-2.51
4.56
-1.27
growth rate 157.3% -100.0% 100.0% -100.0%
Net Income 0.59
1.53
-2.66
4.23
-1.27
growth rate 157.8% -100.0% 100.0% -100.0%
Gross Profit 5.89
5.09
5.34
5.53
4.48
growth rate -13.5% 4.7% 3.6% -19.0%

Growth Grade & Financial Ratios

All financial ratios below are calculated based on latest annual statements available and present the most up to date snapshot of a company finances.

Growth Grade

Historical Growth Grade:

D (37.18)

YOY Growth Grade:

E (20.39)

Click on buttons above for detailed yearly growth rates.

Market Ratios

Profitability Ratios

Liquidity Ratios

Efficiency Ratios

Value Price

PE and EPS

Historical Current Forward
PE 39.27 39.27 27.49
EPS / Growth 0.0% 0.01

Value Price & Investment Recovery Time

Read more about Stock2Own value price in Stock Market: Fundamental Analysis.

Equity Growth Rate: 0.0%

Estimates Pessimistic Moderate Optimistic My Numbers
Rate of Return 15.0%
MOS Price % 50 %
Future EPS Growth 0.0% 0.0% 0.0%
Future PE 0.00 22.25 22.25
Future EPS 0.01 0.01 0.01
Value Price
MOS %
0.00
-100.0%
0.04
-85.2%
0.04
-85.2%
MOS Price 0.00 0.02 0.02
IRT 37.14 37.14 37.14

Graham Number:

NOTE: The Graham Number applies only to certain types of stocks in combination with a number of other criteria.

Read more about Graham Number in Stock Market: Fundamental Analysis.

Price Chart

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.

Risk / Reward Ratios

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.